The use of alternative molecular testing methods such as direct sequencing or in situ hybridization is not recommended because of the diversity of NTRK fusions observed in various central nervous system (CNS) tumours, with NTRK1/2/3 interacting with multiple fusion partners [10]. This evidence concerns the gene NTRK1 and neoplasm.